CCEP
Signal
Bearish Setup2
Price
1
Move-1.59%Negative session
Volume
1
Volume0.0× avgLight volume
Technical
1
RSIRSI 49Momentum negative
PRICE
Prev Close
94.18
Open
93.44
Day Range92.60 – 93.93
92.60
93.93
52W Range84.66 – 110.90
84.66
110.90
31% of range
VOLUME & SIZE
Avg Volume
1.9M
FUNDAMENTALS
P/E Ratio
18.6x
EPS (TTM)
Div Yield
0.04%
Beta
0.88
Market-like
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +16% YoY
Valuation
FAIR
P/E 19x vs ~20x sector
Health
MODERATE
CR 0.8 (low) · FCF $4.79/sh
Bullish
Key MetricsTTM
Market Cap$35.53B
Revenue TTM$41.34B
Net Income TTM$3.36B
Free Cash Flow$4.42B
Gross Margin35.6%
Net Margin9.3%
Operating Margin13.4%
Return on Equity24.5%
Return on Assets6.5%
Debt / Equity1.38
Current Ratio0.80
EPS TTM$4.32

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong2 watch2 concern
51/100
Liquidity
0.80Concern
Leverage
1.38Watch
Coverage
10.3xStrong
ROE
24.5%Strong
ROIC
9.5%Watch
Cash
$918MConcern
ANALYST COVERAGE27 analysts
BUY
+18.7%upside to target
L $108.00
Med $110.00consensus
H $114.00
Buy
1556%
Hold
1141%
Sell
14%
15 Buy (56%)11 Hold (41%)1 Sell (3%)
Full report →
Stock Health
Composite Score
2 of 4 signals bullish
5/10
Technicals
RSI RangeRSI 49 — Bearish momentum
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 0.80 — liquidity risk

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings Report · Before OpenMay 5, 2026
Tomorrow
DEx-Dividend DateAug 2, 2026
In 90 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

UptrendGolden Cross · 50D leads 200D by 7.8%

+1.5% vs SMA 50 · +9.4% vs SMA 200

Momentum

RSI49.3
Neutral territory
MACD+2.30
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$110.9+19.7%
Current
$92.68
EMA 50
$91.89-0.8%
EMA 200
$84.71-8.6%
52W Low
$84.66-8.7%
52-Week RangeMid-range
$84.6631th %ile$110.9
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 9 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$20.9B
$20.9B$20.9B
$4.08
±7%
High9
FY2026(current)
$21.9B
$21.2B$22.2B
+4.5%$4.53+11.0%
±8%
High9
FY2027
$22.7B
$22.0B$23.1B
+3.8%$4.95+9.3%
±10%
High9
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryCCEP
Last 8Q
+2.2%avg beat
Beat 6 of 8 quartersMissed 1 Estimates rising
Q4'22
+5%
Q2'23
+5%
Q4'23
+2%
Q2'24
+3%
Q4'24
+1%
Q1'25
-1%
Q3'25
+2%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Morgan StanleyOverweight → Reduce
Aug 7
DOWNGRADE
Morgan StanleyOverweight
Dec 9
UPGRADE
Exane BNP ParibasOutperform → Neutral
Sep 10
DOWNGRADE
Exane BNP ParibasOutperform
Jan 12
UPGRADE
UBSBuy
Aug 3
UPGRADE
Financials
Dividends2.51% yield
5 yrs of payments
Annual Yield2.51%
Semi-Annual Div.$0.9608
Est. Annual / Share$1.92
FrequencySemi-Annual
Q4'22
Q2'23
Q4'23
Q2'24
Q4'24
Q2'25
Q4'25
Q2'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
TRUIST FINANCIAL CORP
4.7M
2
Sumitomo Mitsui Trust Holdings, Inc.
1.7M
3
Marathon Asset Management Ltd
1.1M
4
ROYAL LONDON ASSET MANAGEMENT LTD
940K
5
Nuveen, LLC
706K
6
ProShare Advisors LLC
581K
7
Handelsbanken Fonder AB
332K
8
Swedbank AB
191K
News & Activity

CCEP News

20 articles · 4h ago

About

fabricación de bebidas no alcohólicas; producción de aguas minerales y otras aguas embotelladas.

CEO
Damian Gammell
Country
United Kingdom